Q: Do you like either of these companies and are either a buy at current levels for a 2-3 year plan. i hold mostly blue chip dividend players so these would just be a small percentage of the portfolio. thanks
5i Research Answer:
ANRG is continuing with its remarkable turnaround, with good results and a growing backlog. Cash flow has turned positive and the balance sheet has improved. Sales growth looks good and it is now profitable. It is not our favourite small cap but we acknowledge its turn from its near-death experience. It is quite expensive on valuation which tempers our interest. GRN is up 177% in a year and has some cash, but we would still consider it too small for serious consideration.